Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting
The company updated the Phase 1b efficacy and safety results [...]
The company updated the Phase 1b efficacy and safety results [...]
Dr. Vibhor Gupta, Founder and Director at Pangaea, said: “We [...]
Omeros received approximately $126 million in cash at closing. In [...]